Successful use of bivalirudin for superior vena cava recanalization and stent placement in a child with heparin-induced thrombocytopenia

John P. Breinholt, Brady S. Moffett, Karen M. Texter, Frank Ing

Research output: Contribution to journalArticle

10 Scopus citations

Abstract

Heparin-induced thrombocytopenia (HIT) is a potentially life-threatening, adverse effect of heparin therapy. Patients with this complication require an alternative approach to anticoagulation. Bivalirudin is a direct thrombin inhibitor with an efficacy comparable to that of heparin, a short half-life, and reduced bleeding complications in adults. We present the case of a 2-year-old boy with HIT Type II who underwent recanalization of an occluded superior vena cava and stent placement, utilizing bivalirudin as anticoagulant.

Original languageEnglish (US)
Pages (from-to)804-807
Number of pages4
JournalPediatric Cardiology
Volume29
Issue number4
DOIs
StatePublished - Jul 1 2008
Externally publishedYes

    Fingerprint

Keywords

  • Anticoagulation
  • Congenital heart disease
  • Thrombosis

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Cardiology and Cardiovascular Medicine

Cite this